CBERWhat's NewSearchSite MapFDA HomeCBER HomeIndexContact Us
Blood | Therapeutics | Vaccines | Cellular & Gene Therapy | Allergenics | Tissue | Devices
Products | Manufacturers | Health Professionals | Reading Room | Meetings & Workshops | Research | About Us


Voluntary Recall of BCG, Live (PACIS)


DATE RECALL INITIATED:

April 10, 2001

PRODUCT / LOT NUMBER / EXPIRATION DATE:

BCG, Live (PACIS), For Intravesical Use
1BC22063 4/2001

MANUFACTURER:

Biochem Pharma Inc.
Sainte-Foy, Quebec
Canada

REASON:

Stability testing at nine months found that the potency of the lot was 1.9 x 106 CFU/mg. This is below the firm’s specification of 2.0 x 106 CFU/mg.


The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.


Last Updated: 4/5/2002